Drug Profile
LY 2828360
Alternative Names: Cannaboid receptor-2 agonist - Eli Lilly; LY2828360Latest Information Update: 08 Feb 2012
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class Non-opioid analgesics
- Mechanism of Action Cannabinoid receptor CB2 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Musculoskeletal pain
Most Recent Events
- 17 Jan 2012 Discontinued - Phase-II for Musculoskeletal pain in Denmark (PO)
- 30 Sep 2011 Eli Lily completes a phase II trial in Musculoskeletal pain in Denmark (NCT01319929)